Article

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

2021-05-12

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global crisis, urgently necessitating the development of safe, efficacious, convenient-to-store, and low-cost vaccine options. A major challenge is that the receptor-binding domain (RBD)-only vaccine fails to trigger long-lasting protective immunity if used solely for vaccination. To enhance antigen processing and cross-presentation in drain...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a1aeb951-7e85-5a8c-9279-f5e5d449394d
DOI: 10.1101/2021.05.12.443228

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2DOI 10.1101/2021.05.12.443228Read

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.Semantic proximity Read

A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primatesSemantic proximity Read

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2Semantic proximity Read

Development of an RBD-Fc fusion vaccine for COVID-19Semantic proximity Read

Incorporation of Sars-Cov-2 Spike Ntd to Rbd-Based Vaccine Improves Immunity and Protection Against Viral VariantsSemantic proximity Read

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in miceSemantic proximity Read

A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2.Semantic proximity Read

Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS-CoV-2 Through Mutant Bacteriophage Qβ-Receptor Binding Domain Conjugate.Semantic proximity Read

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernSemantic proximity Read

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralizationSemantic proximity Read

Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBDSemantic proximity Read

Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus InfectionsSemantic proximity Read